Robert R Henry

10PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutrigenomics and personalised nutritionCancer geneticsNutritional epidemiologyMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 19, 2019
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial.

Lawrence Blonde, Julio Rosenstock, Stefano Del Prato

|Feb 08, 2019
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Thomas Danne, Satish Garg, Anne L Peters

|Nov 18, 2018
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.

Kenneth Cusi, Fernando Bril, Diana Barb

|Jun 16, 2018
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.

Ilse C Schrieks, Anna Nozza, Barbara E Stähli

|Mar 02, 2018
Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials.

Robert R Henry, Dirk Müller-Wieland, Pam R Taub

|Feb 14, 2018
Alirocumab vs usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial.

Kausik K Ray, Lawrence A Leiter, Dirk Müller-Wieland

Pageof 2

Frequent Collaborators

3 joint publications

Stefano Del Prato

3 joint publications

Jeremy Pettus

2 joint publications

Julio Rosenstock

2 joint publications

Lawrence A Leiter